Article

SLT without gonioscopy lens successful

Selective laser trabeculoplasty (SLT) without the use of a gonioscopy lens was performed successfully and still decreased IOP over 6 months, said Michael Belkin, MD.

Orlando-Selective laser trabeculoplasty (SLT) without the use of a gonioscopy lens was performed successfully and still decreased IOP over 6 months, said Michael Belkin, MD.

Dr. Belkin, of the Goldschleger Eye Research Institute, Tel-Aviv University, Tel-Hashomer, Israel, highlighted his results during a session on glaucoma surgery, wound healing, and lasers at the 2014 meeting of the Association for Research in Vision and Ophthalmology.

In his study, a control group of 16 patients had conventional SLT with 100 laser spots through a gonioscope for 360° directly on the trabecular meshwork. A trial group had irridation performed by the same laser and with the same irridation parameters but without the gonioscope. All surgeries were performed by the same surgeon, Dr. Belkin said.

 

Patients did not have a change in their topical glaucoma therapy during the 6-month study period.

In the trial group, the average IOP decreased from 20.21 to 15.50 mm Hg at 6 months. In the control group, the IOP at 6 months dropped from 21.14 to 15 mm Hg. The IOP reduction difference between the two groups was not statistically significant, Dr. Belkin noted.

The control group had significantly higher complications as well as higher anterior chamber inflammation and superficial punctate keratitis rates.

“You don’t need the gonioscopy lens to do SLT,” Dr. Belkin said. “Transscleral SLT is as efficacious as traditional SLT and it lowers corneal- and gonioscopy-induced side effects.”

Eliminating the use of the gonioscope in SLT could provide wider access to the procedure among physicians, Dr. Belkin said.

 

Additionally, although there is not yet research to support it, SLT without use of a gonioscope may open a treatment avenue for angle-closure glaucoma, he added.

 

For more articles in this issue of Ophthalmology Times’ Conference Brief, click here.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.